1248800

David Weisman, M.D. — FEI 3031508738

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 9, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Abington, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance